Clinacin 25 mg Tablets for Dogs
Clinacin 25 mg Tablets for Dogs
Authorised
- Clindamycin hydrochloride
Product identification
Medicine name:
Clinacin 25 mg Tablets for Dogs
Clinacin 25mg Tabletten
Active substance:
- Clindamycin hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride27.14/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure, containing 100 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 400531.00.00
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0112/002
Concerned member states:
-
Austria
-
Denmark
-
France
-
Germany
-
Greece
-
Portugal
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (RTF)
Published on: 6/01/2025
How useful was this page?:
